The global medical device contract manufacturing market size was estimated at USD 76.8 billion in 2024 and is projected to reach USD 151.98 billion by 2030, growing at a CAGR of 12.36% from 2025 to 2030. This rapid growth reflects the dynamic evolution of the medical device industry worldwide, which is being driven by a rising prevalence of diseases, increasing demand for innovative and advanced medical devices, and a growing emphasis on cost-effective manufacturing solutions.

Contract manufacturing organizations (CMOs) play a crucial role in this ecosystem by helping medical device companies streamline their operations, thereby enhancing efficiency and accelerating the time-to-market for new products. The ability of CMOs to handle complex manufacturing processes allows medical device firms to bring products to market faster, which is increasingly important in a competitive and fast-paced industry.

The expansion of medical device CMOs is largely fueled by the growing trend of original equipment manufacturers (OEMs) outsourcing their production needs. This outsourcing is driven by emerging healthcare requirements and the numerous benefits offered by CMOs, including scalability and operational flexibility. These advantages enable medical device companies to adapt quickly to changes in market demand and fluctuations.

By partnering with CMOs, medical device companies can focus more intently on their core strengths, such as research and development (R&D) and marketing activities. Meanwhile, they can rely on CMOs to provide specialized manufacturing expertise, scalable production capabilities, and cost efficiencies. This collaboration allows for a more streamlined and effective approach to product development and commercialization within the medical device industry.

Key Market Trends & Insights:

• In 2024, the Asia Pacific region emerged as the dominant player in the global medical device contract manufacturing market, capturing the largest revenue share of 41.37%. This dominance highlights the region’s growing importance as a hub for medical device manufacturing, driven by factors such as increasing healthcare investments, a large patient population, and expanding medical infrastructure.

• Within the Asia Pacific market, China held the largest share, underscoring its position as a key market and manufacturing base in the region. China’s robust manufacturing capabilities, coupled with supportive government policies and a growing demand for advanced medical devices, have solidified its leadership in this space.

• When looking at the market based on product categories, the class III medical devices segment is projected to grow at the fastest compound annual growth rate (CAGR) of 11.48% during the forecast period. This segment typically includes high-risk, complex devices that require stringent regulatory approvals, reflecting a rising demand for advanced and innovative medical technologies.

• In terms of services, the accessories manufacturing segment dominated the market with the largest revenue share of 48.7% in 2024. This indicates that manufacturing services related to device accessories constitute a significant portion of the contract manufacturing activities, driven by their essential role in enhancing the functionality and usability of medical devices.

• By therapeutic area, the cardiovascular devices segment led the market with the largest revenue share of 27.17% in 2024. This leadership is reflective of the growing prevalence of cardiovascular diseases globally and the continuous need for innovative cardiovascular device solutions, which in turn fuels demand within the contract manufacturing sector.

Order a free sample PDF of the Medical Device Contract Manufacturing Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 76.8 Billion

• 2030 Projected Market Size: USD 151.98 Billion

• CAGR (2025-2030): 12.36%

• Asia Pacific: Largest market in 2024

Key Companies & Market Share Insights:

Key players in the market are actively engaging in a variety of strategic initiatives aimed at enhancing their service offerings and gaining a competitive edge. These initiatives include launching new products, forming strategic partnerships and collaborations, as well as pursuing mergers and acquisitions. Such efforts are critical for companies to broaden their capabilities, expand their market reach, and stay ahead in a highly competitive industry.

A notable example occurred in August 2023, when Eurofins BioPharma Product Testing completed the acquisition of ENCO, a move that significantly strengthened Eurofins’ capabilities in the ophthalmic and medical device sectors. This acquisition not only expanded Eurofins’ expertise in these specialized areas but also increased its operational presence in the southeastern region of the United States. Additionally, the acquisition brought in valuable experience related to ophthalmic products, medical devices, and animal health, further diversifying and enriching Eurofins’ portfolio and service capacity.

Key Players

• Jabil Inc.

• Thermo Fisher Scientific Inc.

• Integer Holdings Corporation

• FLEX LTD.

• Sanmina Corporation

• Celestica Inc.

• Phillips-Medisize

• Plexus Corp.

• Nipro Corporation

• Viant Technology LLC

• West Pharmaceutical Services, Inc.

• Mack Molding

• Cirtec Medical

• Cogmedix

• Synecco Ltd

• TE Connectivity

• Keller Technology Corp.

• HDA Technology, Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The medical device contract manufacturing market is experiencing strong growth driven by increasing demand for innovative medical devices, rising healthcare needs, and the benefits of outsourcing production. Contract manufacturers help medical device companies improve efficiency, reduce costs, and accelerate product launches. The market growth is supported by advancements in technology, growing outsourcing trends, and a focus on scalability and flexibility to adapt to changing market demands.